NO20014824L - Bicykliske heteroaromatiske forbindelser anvendelige som LH- agonister - Google Patents

Bicykliske heteroaromatiske forbindelser anvendelige som LH- agonister

Info

Publication number
NO20014824L
NO20014824L NO20014824A NO20014824A NO20014824L NO 20014824 L NO20014824 L NO 20014824L NO 20014824 A NO20014824 A NO 20014824A NO 20014824 A NO20014824 A NO 20014824A NO 20014824 L NO20014824 L NO 20014824L
Authority
NO
Norway
Prior art keywords
agonists
compounds useful
heteroaromatic compounds
bicyclic heteroaromatic
bicyclic
Prior art date
Application number
NO20014824A
Other languages
English (en)
Other versions
NO328826B1 (no
NO20014824D0 (no
Inventor
Gerrildina Geziena Gerritsma
Nicole Corine Renee Va Straten
Anton Egbert Peter Adang
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20014824D0 publication Critical patent/NO20014824D0/no
Publication of NO20014824L publication Critical patent/NO20014824L/no
Publication of NO328826B1 publication Critical patent/NO328826B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO20014824A 1999-04-08 2001-10-04 Bicykliske heteroaromatiske forbindelser anvendelige som LH-agonister samt farmasoytiske preparater inneholdende slike NO328826B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99201152 1999-04-08
PCT/EP2000/002865 WO2000061586A1 (en) 1999-04-08 2000-04-03 Bicyclic heteroaromatic compounds useful as lh agonists

Publications (3)

Publication Number Publication Date
NO20014824D0 NO20014824D0 (no) 2001-10-04
NO20014824L true NO20014824L (no) 2001-10-04
NO328826B1 NO328826B1 (no) 2010-05-25

Family

ID=8240094

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014824A NO328826B1 (no) 1999-04-08 2001-10-04 Bicykliske heteroaromatiske forbindelser anvendelige som LH-agonister samt farmasoytiske preparater inneholdende slike

Country Status (30)

Country Link
US (2) US6569863B1 (no)
EP (1) EP1171443B1 (no)
JP (1) JP4854856B2 (no)
KR (1) KR100691546B1 (no)
CN (1) CN1177848C (no)
AR (1) AR028474A1 (no)
AT (1) ATE299507T1 (no)
AU (1) AU772258B2 (no)
BR (1) BRPI0009558B1 (no)
CA (1) CA2368834C (no)
CO (1) CO5160348A1 (no)
CZ (1) CZ300832B6 (no)
DE (1) DE60021262T2 (no)
DK (1) DK1171443T3 (no)
ES (1) ES2245304T3 (no)
HK (1) HK1041266B (no)
HU (1) HU229002B1 (no)
ID (1) ID30502A (no)
IL (2) IL145483A0 (no)
MX (1) MXPA01010144A (no)
NO (1) NO328826B1 (no)
NZ (1) NZ514445A (no)
PE (1) PE20010030A1 (no)
PL (1) PL219316B1 (no)
PT (1) PT1171443E (no)
RU (1) RU2248979C2 (no)
TR (1) TR200102839T2 (no)
TW (1) TW564247B (no)
WO (1) WO2000061586A1 (no)
ZA (1) ZA200107917B (no)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1322651E (pt) 2000-09-22 2008-02-28 Organon Nv Compostos heteroaromáticos bicíclicos
GB0100622D0 (en) 2001-01-10 2001-02-21 Vernalis Res Ltd Chemical compounds V111
DE10108481A1 (de) * 2001-02-22 2002-10-24 Bayer Ag Pyridylpyrimidine
JP4263094B2 (ja) 2001-09-04 2009-05-13 ナームローゼ・フエンノートチヤツプ・オルガノン ＬＨ及びＦＳＨ合併アゴニスト作用を有するグリシン置換チエノ［２，３−ｄ］ピリミジン
TWI228508B (en) * 2001-09-04 2005-03-01 Akzo Nobel Nv Thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity
ME00355B (me) 2002-06-06 2010-06-30 Ptp Group Ltd Kristalisan polietilen tereftalat, koji sadrži silicijum, i postupak za njegovo dobijanje
US6974870B2 (en) 2002-06-06 2005-12-13 Boehringer Ingelheim Phamaceuticals, Inc. Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
EP1633756B1 (en) 2003-04-09 2008-12-24 Biogen Idec MA Inc. A2a adenosine receptor antagonists
US7674791B2 (en) 2003-04-09 2010-03-09 Biogen Idec Ma Inc. Triazolopyrazines and methods of making and using the same
WO2004092170A2 (en) 2003-04-09 2004-10-28 Biogen Idec Ma Inc. Triazolotriazines and pyrazolotriazines useful as a2a adenosine receptor antagon ists
JPWO2005019225A1 (ja) * 2003-08-21 2007-11-01 杏林製薬株式会社 Ｎｋ１受容体拮抗作用を有する化合物の製造方法及びその製造中間体
US7550485B2 (en) * 2003-10-14 2009-06-23 Wyeth Substituted N-heterocycle derivatives and methods of their use
US7816353B2 (en) * 2003-10-24 2010-10-19 Exelixis, Inc. P70S6 kinase modulators and method of use
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7645881B2 (en) * 2004-07-22 2010-01-12 Ptc Therapeutics, Inc. Methods for treating hepatitis C
EP1962892A4 (en) * 2005-11-22 2011-10-12 Univ South Florida INHIBITION OF CELL PROLIFERATION
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
JP2009537551A (ja) * 2006-05-17 2009-10-29 アメリカ合衆国 ホルモン受容体を調節するためのピリミジン低分子量リガンド
US7592353B2 (en) 2006-06-06 2009-09-22 Boehringer Ingelheim International Gmbh Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
RU2444524C2 (ru) * 2006-08-21 2012-03-10 Дженентек, Инк. Азабензотиофенильные соединения и способы применения
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
CN101801930B (zh) * 2007-09-14 2013-01-30 奥梅-杨森制药有限公司 1,3-二取代的-4-苯基-1h-吡啶-2-酮
BRPI0816767B8 (pt) 2007-09-14 2021-05-25 Addex Pharmaceuticals Sa composto 4-fenil-3,4,5,6-tetra-hidro-2h,1'h-[1,4']bipiridi¬nil-2'-onas 1',3'-dissubstituídas, composição farmacêutica e uso dos mesmos
AU2008297876B2 (en) 2007-09-14 2011-07-07 Addex Pharma S.A. 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
RU2528340C2 (ru) * 2007-10-18 2014-09-10 Бёрингер Ингельхайм Интернациональ Гмбх ПОЛУЧЕНИЕ ДИГИДРОТИЕНО[3,2-d]ПИРИМИДИНОВ И ПРОМЕЖУТОЧНЫХ ПРОДУКТОВ, ПРИМЕНЯЮЩИХСЯ ДЛЯ ИХ СИНТЕЗА
ES2637794T3 (es) 2007-11-14 2017-10-17 Janssen Pharmaceuticals, Inc. Derivados de imidazo[1,2-A]piridina y su uso como moduladores alostéricos positivos de receptores MGLUR2
AU2009289784B2 (en) 2008-09-02 2012-03-22 Addex Pharma S.A. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
WO2010043396A1 (en) 2008-10-16 2010-04-22 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
WO2010060589A1 (en) 2008-11-28 2010-06-03 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
US8946205B2 (en) 2009-05-12 2015-02-03 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
MY161325A (en) 2009-05-12 2017-04-14 Janssen Pharmaceuticals Inc 1, 2, 4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
PL2649069T3 (pl) 2010-11-08 2016-01-29 Janssen Pharmaceuticals Inc Pochodne 1,2,4-triazolo[4,3-a]pirydyny i ich zastosowanie jako dodatnich allosterycznych modulatorów receptorów mGluR2
AU2011328203B2 (en) 2010-11-08 2015-03-19 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
CN103261195B (zh) 2010-11-08 2015-09-02 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
EP2734239A2 (en) 2011-07-18 2014-05-28 Arts Biologics A/S Long acting luteinizing hormone (lh) compound
EP3048106B1 (en) 2011-11-23 2019-11-06 Cancer Research Technology Limited Thienopyrimidine as inhibitors of atypical protein kinase c
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
UA121965C2 (uk) 2014-01-21 2020-08-25 Янссен Фармацевтика Нв Комбінації, які містять позитивні алостеричні модулятори або ортостеричні агоністи метаботропного глутаматергічного рецептора 2 підтипу, та їх застосування
KR102461134B1 (ko) 2014-01-21 2022-10-28 얀센 파마슈티카 엔.브이. 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
CN107602585A (zh) * 2017-10-23 2018-01-19 遵义医学院 噻吩并吡啶双杂环化合物的制备工艺
BR102019022529A2 (pt) * 2019-10-25 2021-05-04 Anhanguera Educacional Ltda. Processo para obtenção de composições farmacêuticas antitumorais através de butadienos push-pull, compostos e seus usos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993013664A2 (en) 1992-01-11 1993-07-22 Schering Agrochemicals Limited Biheterocyclic fungicidal compounds
TW449600B (en) 1994-04-19 2001-08-11 Takeda Chemical Industries Ltd Condensed-ring thiophene derivatives, their production and use
JP3854648B2 (ja) * 1994-04-19 2006-12-06 武田薬品工業株式会社 縮合チオフェン誘導体、その製造法及び用途
ATE225351T1 (de) * 1994-11-08 2002-10-15 Takeda Chemical Industries Ltd Thienopyridin und thienopyrimidinderivate und ihre verwendung als entzündungshemmende mittel
WO1997014697A1 (en) 1995-10-19 1997-04-24 Takeda Chemical Industries, Ltd. Thienopyridine derivatives as gonadotropin releasing hormone antagonists
JPH09169767A (ja) * 1995-10-19 1997-06-30 Takeda Chem Ind Ltd 複素環化合物、その製造法および用途
JPH09169766A (ja) * 1995-10-19 1997-06-30 Takeda Chem Ind Ltd チエノピリジン誘導体，その製造法および用途
WO1997041126A1 (en) 1996-04-26 1997-11-06 Takeda Chemical Industries, Ltd. Thienopyridine derivatives, their production and use

Also Published As

Publication number Publication date
CA2368834C (en) 2009-11-03
US6569863B1 (en) 2003-05-27
JP4854856B2 (ja) 2012-01-18
BRPI0009558B1 (pt) 2016-10-25
RU2248979C2 (ru) 2005-03-27
NZ514445A (en) 2003-07-25
KR100691546B1 (ko) 2007-03-12
PL350964A1 (en) 2003-02-24
HK1041266A1 (en) 2002-07-05
KR20010103801A (ko) 2001-11-23
ID30502A (id) 2001-12-13
WO2000061586A1 (en) 2000-10-19
DE60021262T2 (de) 2006-01-05
DK1171443T3 (da) 2005-11-07
NO328826B1 (no) 2010-05-25
US20030212081A1 (en) 2003-11-13
MXPA01010144A (es) 2002-04-24
CZ300832B6 (cs) 2009-08-19
ZA200107917B (en) 2003-09-23
ES2245304T3 (es) 2006-01-01
EP1171443A1 (en) 2002-01-16
EP1171443B1 (en) 2005-07-13
AU3816600A (en) 2000-11-14
TW564247B (en) 2003-12-01
HUP0200653A2 (en) 2002-06-29
IL145483A (en) 2007-06-03
CA2368834A1 (en) 2000-10-19
CZ20013605A3 (cs) 2002-03-13
CO5160348A1 (es) 2002-05-30
BR0009558A (pt) 2002-02-19
CN1177848C (zh) 2004-12-01
AU772258B2 (en) 2004-04-22
NO20014824D0 (no) 2001-10-04
AR028474A1 (es) 2003-05-14
PE20010030A1 (es) 2001-01-27
IL145483A0 (en) 2002-06-30
HU229002B1 (en) 2013-07-29
DE60021262D1 (de) 2005-08-18
JP2002541259A (ja) 2002-12-03
US6841553B2 (en) 2005-01-11
PL219316B1 (pl) 2015-04-30
CN1349535A (zh) 2002-05-15
ATE299507T1 (de) 2005-07-15
PT1171443E (pt) 2005-11-30
HUP0200653A3 (en) 2004-07-28
HK1041266B (zh) 2005-09-16
TR200102839T2 (tr) 2002-04-22

Similar Documents

Publication Publication Date Title
NO20014824L (no) Bicykliske heteroaromatiske forbindelser anvendelige som LH- agonister
NO20013671D0 (no) Substituerte bicycliske derivater nyttige som anticancer midler
NO20014412L (no) Forbindelser nyttige som anti-inflammatoriske midler
IS6024A (is) Ný efnasambönd
PT1202994E (pt) Novos compostos
DK1175408T3 (da) Pyrimidinonforbindelser
DK1218382T3 (da) Bicykliske imidazo-3-ylaminderivater
ATE305470T1 (de) Naphthyridinverbindungen
DE50015443D1 (de) Bicyclische imidazo-5-yl-aminderivate
IS6139A (is) Ný efnasambönd
DK1228073T3 (da) Imidazolforbindelser som phosphodiesterase VII-inhibitorer
NO20016201D0 (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
NZ513732A (en) Heterocyclic benzenesulphonamide compounds as bradykinine antagonists
NO20021251D0 (no) Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendelige som D4antagonister
IS2531B (is) Bísýklísk heteróarómatísk efnasambönd
NO20020485L (no) Heterocykliske forbindelser som inhiberer angiogenese
IS6141A (is) Ný efnasambönd
DK1261588T3 (da) Imidazolforbindelser som alfa2-adrenoceptorantagonister
ID30056A (id) Agonis-agonis 5-htif
DK1207159T3 (da) Heteroaromatiske derivater som dopamin-D4-receptorantagonister
SI1155013T1 (en) Heterocyclic benzenesulphonamide compounds as bradykinine antagonists
SE9904422D0 (sv) New compounds
SE9904228D0 (sv) New compounds
SE9900071D0 (sv) New compounds

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: MERCK SHARP & DOHME BV, NL

MM1K Lapsed by not paying the annual fees